V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009381 | 310004418 | 1.61 | 92 | Curative (C) | 2016-07-07 | 2016-07-08 | LEAM | N | N | 310017282 | LEAM |
| 310009382 | 310004419 | 1.66 | 61.2 | Palliative (P) | 2018-10-31 | 2018-10-31 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017284 | CISPLATIN + GEMCITABINE |
| 310009383 | 310007857 | 1.66 | 104 | Not known (9) | 2016-02-08 | 2018-04-02 | PEMBROLIZUMAB | 02 | N | 310017289 | PEMBROLIZUMAB |
| 310009384 | 310004423 | null | 101.9 | Palliative (P) | 2014-07-25 | 2014-07-27 | PEMBROLIZUMAB | 02 | null | 310017300 | PEMBROLIZUMAB |
| 310009385 | 310004423 | 1.96 | 79.95 | null | 2017-07-11 | 2017-09-03 | Gemcitabine + Paclitaxel | N | N | 310017300 | GEMCITABINE + PACLITAXEL |
| 310009386 | 310004423 | 1.79 | 73 | Palliative (P) | 2013-10-24 | 2013-11-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 310017300 | CISPLATIN + GEMCITABINE |
| 310009387 | 310004426 | null | 58.2 | Disease modification (D) | 2017-08-09 | 2017-08-15 | ALL UKALL2011 Maintenance C4 | N | N | 310017325 | NOT MATCHED |
| 310009389 | 310004429 | 1.78 | 50.2 | Curative (C) | 2016-03-20 | 2016-05-18 | LEAM | N | N | 310017341 | LEAM |
| 310009390 | 310004431 | null | 72 | Curative (C) | 2017-07-21 | 2017-08-07 | IVE | N | N | 310017348 | IVE |
| 310009391 | 310004433 | null | 58.3 | Curative (C) | 2014-07-18 | 2014-08-05 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310017357 | GEMCITABINE |
| 310009392 | 310004434 | 1.59 | 86.6 | Palliative (P) | 2014-12-05 | 2014-12-14 | PEMBROLIZUMAB | null | null | 310017365 | PEMBROLIZUMAB |
| 310009393 | 310004435 | 1.85 | 14.8 | Palliative (P) | 2015-04-22 | 2015-05-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017366 | CISPLATIN + GEMCITABINE |
| 310009394 | 310009698 | 1.5 | 82.9 | Curative (C) | 2015-09-17 | 2017-01-11 | IVE | N | N | 310017373 | IVE |
| 310009395 | 310004436 | 1.73 | 85.6 | Palliative (P) | 2014-12-05 | 2015-01-03 | CISPLATIN + GEMCITABINE | 2 | N | 310017385 | CISPLATIN + GEMCITABINE |
| 310009396 | 310004437 | 1.55 | 81.01 | Palliative (P) | 2017-03-06 | 2017-07-31 | GEM-P | N | N | 310017385 | GEMCITABINE + PACLITAXEL |
| 310009398 | 310010676 | 1.62 | 73.2 | Curative (C) | 2015-05-21 | 2015-05-25 | LEAM | N | N | 310017421 | LEAM |
| 310009399 | 310004443 | null | 25.2 | Palliative (P) | 2015-09-08 | 2015-09-08 | PEMBROLIZUMAB | N | N | 310017432 | PEMBROLIZUMAB |
| 310009400 | 310004447 | 1.58 | 83 | Curative (C) | 2016-08-21 | 2016-08-25 | BEAM | N | N | 310017474 | BEAM |
| 310009402 | 310007873 | 1.78 | 55.5 | Disease modification (D) | 2016-07-03 | 2016-07-10 | LEAM | null | null | 310017503 | LEAM |
| 310009403 | 310004456 | 1.63 | 72.4 | Neo-adjuvant (N) | 2017-08-13 | 2017-10-24 | IVE | 2 | N | 310017513 | IVE |
| 310009404 | 310007875 | 1.78 | 83 | Palliative (P) | 2012-05-10 | 2013-10-15 | Olaratumab | 2 | null | 310017518 | NOT MATCHED |
| 310009405 | 310004463 | 1.73 | 172 | Palliative (P) | 2017-01-15 | 2017-01-15 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 310017565 | NOT MATCHED |
| 310009406 | 310004464 | null | 90.9 | Palliative (P) | 2017-12-28 | 2018-01-02 | PEMBROLIZUMAB | N | N | 310017573 | PEMBROLIZUMAB |
| 310009407 | 310004465 | 1.71 | 58.4 | Disease modification (D) | 2017-11-25 | 2017-12-03 | GEM-P | N | null | 310017575 | GEMCITABINE + PACLITAXEL |
| 310009408 | 310004465 | 1.6 | 67.9 | null | 2017-07-23 | 2017-11-21 | IVE | N | N | 310017575 | IVE |
| 310009409 | 310004466 | 1.53 | 50.8 | Palliative (P) | 2019-01-03 | 2019-01-05 | Carboplatin + Liposomal Doxorubicin | N | N | 310017581 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009410 | 310007882 | 1.81 | 63 | Curative (C) | 2014-12-13 | 2014-12-18 | BEAM | N | N | 310017601 | BEAM |
| 310009411 | 310007883 | 1.66 | 89 | Curative (C) | 2018-12-05 | 2019-01-02 | Mini BEAM | N | N | 310017616 | BEAM |
| 310009412 | 310007884 | 1.61 | 62 | Curative (C) | null | 2017-12-17 | LEAM | 02 | N | 310017634 | LEAM |
| 310009413 | 310004474 | 1.93 | null | Palliative (P) | 2019-03-04 | 2019-08-25 | Brentuximab | 02 | N | 310017644 | BRENTUXIMAB |
| 310009414 | 310004477 | 1.61 | 70.4 | Curative (C) | 2016-09-21 | 2016-09-28 | PCE2BO (Etopophos®) | N | N | 310017649 | NOT MATCHED |
| 310009415 | 310007888 | null | 87.5 | Curative (C) | null | 2014-08-17 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | Y | 310017651 | GEMCITABINE |
| 310009416 | 310007889 | 1.72 | null | Curative (C) | 2015-01-26 | 2015-02-01 | Brentuximab Vedotin | 02 | N | 310017682 | BRENTUXIMAB |
| 310009418 | 310007891 | 1.66 | 87.5 | Adjuvant (A) | 2019-04-28 | 2019-05-08 | LEAM | 2 | N | 310017711 | LEAM |
| 310009419 | 310004482 | null | null | Palliative (P) | 2017-02-08 | 2017-07-01 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310017721 | GEMCITABINE |
| 310009420 | 310004487 | 1.8 | 0 | Palliative (P) | 2015-01-10 | 2015-01-11 | Carboplatin + Liposomal Doxorubicin | N | N | 310017726 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009422 | 310004489 | 1.59 | 75 | Curative (C) | null | 2019-03-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017733 | CISPLATIN + GEMCITABINE |
| 310009423 | 310007895 | 1.5 | 72.9 | Palliative (P) | 2017-06-24 | 2017-09-22 | Carboplatin + Liposomal Doxorubicin | N | N | 310017744 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009424 | 310007896 | 1.6 | 87.2 | null | 2017-01-14 | 2018-03-19 | PEMBROLIZUMAB | N | N | 310017746 | PEMBROLIZUMAB |
| 310009425 | 310007897 | 1.74 | 67.5 | Curative (C) | 2015-10-28 | 2015-11-07 | BEAM | N | N | 310017775 | BEAM |
| 310009426 | 310004499 | 1.69 | null | Curative (C) | 2018-04-08 | 2018-05-13 | IVE | N | N | 310017816 | IVE |
| 310009427 | 310004500 | 1.53 | 76 | Palliative (P) | 2014-04-14 | 2014-05-01 | CARBOPLATIN + LIPOSOMAL DOX | 02 | N | 310017829 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009428 | 310007903 | 1.65 | null | Palliative (P) | 2015-06-09 | 2015-06-12 | null | 02 | N | 310017832 | NOT MATCHED |
| 310009429 | 310007904 | 1.74 | 93.5 | Curative (C) | 2017-01-14 | 2017-04-16 | BEAM | N | N | 310017855 | BEAM |
| 310009430 | 310004503 | 1.65 | 50.2 | Palliative (P) | 2017-08-09 | 2017-08-17 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310017864 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009431 | 310004504 | 1.81 | 92 | Palliative (P) | null | 2015-11-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | null | 310017871 | ESHAP |
| 310009432 | 310004507 | 1.7 | 32.8 | null | 2018-08-01 | 2018-08-01 | Etoposide oral | 02 | N | 310017875 | ETOPOSIDE |
| 310009434 | 310004511 | 1.73 | 62.3 | Adjuvant (A) | 2010-12-28 | 2014-02-13 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310017881 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310009435 | 310004513 | null | 53.4 | null | null | 2014-12-05 | Methotrexate intrathecal | 02 | N | 310017898 | METHOTREXATE INTRATHECAL |
| 310009436 | 310004515 | 1.81 | null | Curative (C) | 2018-03-19 | 2018-03-19 | CHOP R - 21 days | Y | N | 310017904 | CHOP R |